Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients, 18-65 years of age
Major depression disorder without psychotic features
Inadequate response to current, ongoing antidepressant treatment as defined by protocol
Having at least one but no more than 2 antidepressant treatment trial failures
Body mass index (BMI) 18.0-35.0 kg/m2 inclusive
You may not be if
Patient currently receives treatment with a combination of 3 or more antidepressants
Significant ongoing use of high doses of barbiturates, benzodiazepines or other anxiolytic drugs
Patient previously received RO4995819
Patient participated in an investigational drug or device trial within 6 months of screening
History of non-response to, or current use of non-pharmacological treatment including Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), or Repetitive Transcranial Magnetic Stimulation (RTMS)
Past or present psychotic symptoms
Clareo Health | ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
